Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × nimotuzumab × Head & Neck × Clear all

Phase

Status

Sponsor Class

OTHER 28 UNKNOWN 1 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 4 sintilimab 2 pembrolizumab 2 anlotinib 2 Radiotherapy, Intensity-Modulated 2 Drug Therapy 2 Aprepitant 2 nimotuzumab 1 nabiximols 1 camrelizumab 1 Platinum Compounds 1 Palonosetron 1 Paclitaxel 1 Ondansetron 1 Olanzapine 1 Gemcitabine 1 Dexamethasone 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03915132 2021-01-29

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

ChineseAMS

Phase 2 Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡